Timothy Eugene Sullivan, Chief Financial Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 3,460 shares at $29.96 ($104K) on 2025-01-17, disclosed to the SEC on 2025-01-21.
Seasonal sale ($104k) by Chief Financial Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.96 | 1,730 | $52K | 50.0% |
| 2 | $29.96 | 1,730 | $52K | 50.0% |
| Total | $29.96 avg | 3,460 | $104K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $86K | — | Filing → |
| APLS | SELL | 2025-10-23 | $280K | — | Filing → |
| APLS | SELL | 2025-09-10 | $2.1M | — | Filing → |